NGL Fine-Chem Dividend 2026 — ₹1.75 Final, Yield 0.06%, Record Date 18 Aug

At its board meeting held on Thursday, 21 May 2026, the Board of Directors of NGL Fine-Chem recommended a final dividend of ₹1.75 per fully paid-up equity share of ₹5 each for the year ended 31 March 2026. Because it is a final dividend, it is a recommendation that requires shareholder approval at the Annual General Meeting (AGM) before it can be paid.

The company confirmed that the 45th AGM will be held on 25 August 2026 through video conferencing. The dividend, once approved, was payable to shareholders on the company's register as of the record date. The statutory auditors, Manek & Associates, issued an unmodified (clean) audit opinion on both standalone and consolidated results — a positive governance signal that the reported numbers carry no auditor qualification.

A "35% dividend" sounds enormous. It is not. That 35% is simply ₹1.75 expressed as a percentage of the ₹5 face value. What actually lands in your bank account depends on the price you paid for the share, which is far higher than ₹5.

In plain terms: if you invest ₹1,00,000 in NGL Fine-Chem at the current price, this dividend pays you roughly ₹60 for the year. The 35% figure is not wrong — it is just measured against a number (₹5) that has nothing to do with what the share costs today. NGL Fine-Chem is a growth-and-capex story, not an income stock, and the yield reflects that.

FY2025-26 was a strong recovery year (all figures consolidated unless stated). Revenue and profit both jumped sharply, and margins expanded — this was operating leverage working in the company's favour.

Standalone PAT was ₹41.63 Cr (EPS ₹67.39). The wholly-owned subsidiary, Macrotech Polychem Pvt. Ltd, adds the gap between standalone and consolidated numbers.

Reported profit is an accounting opinion; cash is a fact. Here the two diverge in an important way. NGL Fine-Chem generated healthy operating cash but spent far more than that on building capacity — leaving negative free cash flow.

The balance sheet is moderately leveraged and getting more so. Non-current borrowings roughly doubled during the year (from ₹25.3 Cr to ₹56.4 Cr) to help fund the capex programme. At 0.33x debt-to-equity the leverage is still comfortable, and cash plus current investments of ₹44.3 Cr comfortably covers the tiny dividend around 41 times over. The key point for a dividend investor is that debt is rising while dividends are being paid — the company is prioritising growth capex over returning cash, and borrowing to bridge the gap. Capital work-in-progress alone stood at ₹94.6 Cr, signalling that the heavy investment phase is not over.

We test sustainability on four measures — earnings coverage, operating-cash coverage, free-cash-flow coverage, and liquidity coverage.

Because the promoter group (the Lawande / Nachane family) holds about 72.5% of the company, roughly ₹0.78 Cr of the ₹1.08 Cr dividend flows to the promoters, and only around ₹0.30 Cr to all public and minority shareholders combined. Mutual-fund and FII ownership is minimal. In many high-promoter-holding companies a large dividend can be a way to route cash to promoters; here the opposite reading is more accurate — the dividend is so small that neither promoters nor minorities gain much. The company's clear preference is to retain cash for capex rather than distribute it. That is arguably shareholder-friendly if the reinvestment earns good returns, but it offers nothing to an income-seeking minority investor.

Since April 2020, dividends in India are taxed in the hands of the shareholder at their applicable income-tax slab rate — there is no separate Dividend Distribution Tax any more. Key rules:

• Dividend is added to your total income and taxed at your slab rate (5% / 20% / 30% plus cess).
• TDS is deducted by the company at 10% if your total dividend from that company in a financial year exceeds ₹5,000 (20% if PAN is not provided).
• If your income is below the taxable limit, you can file Form 15G / 15H to avoid TDS.

NGL Fine-Chem's FY2025-26 final dividend of ₹1.75 per share is best understood as a token, symbolic payout rather than a source of income. The headline "35%" is a face-value artefact; the real yield is roughly 0.06%, and the amount has not changed in eight years even as profit more than doubled.

The positives: a genuine and uninterrupted eight-year payment record, a clean audit opinion, a strong FY26 recovery (revenue +36%, PAT +128%, EBITDA margin up 600 bps), an easily affordable payout (2.3% of profit), and healthy liquidity relative to the dividend.

The negatives: negative free cash flow, rising debt, a stretched receivable book, and a dividend that has been completely static — delivering no income growth to shareholders. This is a growth-and-capex company that pays a nominal dividend, not a dividend stock. Investors should judge it on its reinvestment and earnings prospects, not on its yield.